---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-055061"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2021-11-08T23:59:59+00:00"
generated_at: "2026-06-28T11:20:22.607268+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences appoints Sam Wadsworth and Shari Lisa Piré to Board of Directors

## Summary
- Sam Wadsworth, Ph.D. (CSO, Ultragenyx Gene Therapy) appointed Class II director; brings 30 years gene therapy experience.
- Shari Lisa Piré, J.D. (Chief Legal & Sustainability Officer, Plume Design) appointed Class III director; over 20 years legal/corporate experience.
- New directors eligible for $40K annual cash retainer, $350K initial equity award vesting over 3 years, plus annual option awards.
- Company states it aims to advance three INDs/CTAs over next three years and continue allogeneic CAR T programs.

## SEC filing metadata
- accession: 0001564590-21-055061
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2021-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/dtil-8k_20211106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-055061
- JSON: https://secwatch.observer/filing/0001564590-21-055061.json
- Plain text: https://secwatch.observer/filing/0001564590-21-055061.txt

## Key facts
- Executive change
  Shari Lisa Piré was appointed as Class III director at PRECISION BIOSCIENCES INC.
  - Action: appointed
  - Role: Class III director
  source text: Shari Lisa Piré to serve as a Class III director on the Company’s Board and as a member of the Nominating and Corporate Governance Committee of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm
- Executive change
  Samuel Wadsworth was appointed as Class II director at PRECISION BIOSCIENCES INC.
  - Action: appointed
  - Role: Class II director
  source text: Samuel Wadsworth, Ph.D. to serve as a Class II director on the Company’s Board and as a member of the Science and Technology Committee of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000156459021055061/0001564590-21-055061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.